Finally, the transferability of the cancer resistance and extended lifespan of the mutant mice via transplantation of BMMNC suggests the possibility of future development of hematopoietic blood cells genome-edited at the conserved sumoylation site of KLF1 for anti-cancer and the extension of healthspan and/or lifespan in animals including humans. The gene discussed is KLF1; the disease is cancer.